Aix Scientifics

Executive Summary

Aix Scientifics is a well-established European Contract Research Organization (CRO) headquartered in Aachen, Germany, with over 25 years of experience in planning, implementing, and evaluating clinical research for pharmaceutical products and medical devices. The company differentiates itself through a multilingual, internet-based remote data system that enables efficient, high-quality data management across international studies. As a private, pre-clinical stage CRO, Aix Scientifics serves as a critical partner for drug developers seeking reliable clinical trial execution and regulatory support. The CRO market is driven by increasing R&D outsourcing by pharmaceutical and biotech companies. Aix Scientifics benefits from its long track record, specialized expertise in complex study designs, and ability to manage multinational trials. The company is well-positioned to capture demand for flexible, technology-enabled clinical research services, particularly in Europe. However, as a private firm with limited public disclosures, growth visibility is moderate. Key risks include competition from larger global CROs and dependence on client project wins.

Upcoming Catalysts (preview)

• Q3 2026Major Client Contract Win for Late-Stage Trial65% success
• Q4 2026Expansion into Central and Eastern Europe50% success
• Q1 2027Regulatory Approval of a Drug Developed with Aix Scientifics' Support40% success